Analytical variability of the Fibrotest proteins

Clinical Biochemistry

Volumn 38, Issue 5, 2005, Pages 473-478

  Rosenthal Allieri, Maria Alessandra ^a   Peritore, Marie Line ^a   Tran, Albert ^a   Halfon, Philippe ^b   Benzaken, Sylvia ^a   Bernard, Alain ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b Laboratoire Alphabio   (France)

Author keywords

Analytical variability; Biological scores of liver fibrosis; Proteins

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; HAPTOGLOBIN;

ANALYTIC METHOD; ARTICLE; AUTOANALYZER; BLOOD CHEMISTRY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; STANDARD;

EID: 17144381690     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.12.012     Document Type: Article

References (25)

1. The French Metavir Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 20 1994 15 20
2. J. Guechot, A. Laudat, A. Loria, L. Serfaty, R. Poupon, and J. Giboudeau Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis Clin. Chem. 42 1996 558 563
3. T. Tsukamoto, T. Yamamoto, T. Ikebe, S. Takemura, T. Shuto, and S. Kubo Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver Hepatogastroenterology 51 2004 777 780
4. K.H. Boeker, C.I. Haberkorn, D. Michels, P. Flemming, M.P. Manns, and R. Lichtinghagen Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C Clin. Chim. Acta 316 2002 71 81
5. V. Leroy, F. Monier, S. Bottari, C. Trocme, N. Sturm, and M.N. Hilleret Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid Am. J. Gastroenterol. 99 2004 271 279
6. R.J. Fontana, and A.S. Lok Noninvasive monitoring of patients with chronic hepatitis C Hepatology 36 2002 S57 S64
7. F. Imbert-Bismut, V. Ratziu, L. Pieroni, F. Charlotte, Y. Benhamou, and T. Poynard Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 2001 1069 1075
8. X. Forns, S. Ampurdanes, J.M. Llovet, J. Aponte, L. Quinto, and E. Martinez-Bauer Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 2002 986 992
9. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, and H.S. Conjeevaram A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
10. R.P. Myers, Y. Benhamou, F. Imbert-Bismut, V. Thibault, M. Bochet, and F. Charlotte Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients AIDS 17 2003 721 725
11. P. Halfon, F. Imbert-Bismut, D. Messous, G. Antoniotti, D. Benchetrit, and P. Cart-Lamy A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease Comp. Hepatol. 1 2002 3
12. F. Imbert-Bismut, D. Messous, V. Thibaut, R.B. Myers, A. Piton, and D. Thabut Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors Clin. Chem. Lab. Med. 42 2004 323 333
13. J.T. Whicher, R.F. Ritchie, A.M. Johnson, S. Baudner, J. Bienvenu, and S. Blirup-Jensen New international reference preparation for proteins in human serum (RPPHS) Clin. Chem. 40 1994 934 938
14. S. Blirup-Jensen Protein standardization III: method optimization basic principles for quantitative determination of human serum proteins on automated instruments based on turbidimetry or nephelometry Clin. Chem. Lab. Med. 39 2001 1098 1109
15. E. Rossi, L. Adams, A. Prins, M. Bulsara, B. de Boer, and G. Garas Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients Clin. Chem. 49 2003 450 454
16. P. Halfon, M. Bourliere, R. Deydier, D. Botta-Fridlund, A. Tran, and I. Portal Independent prospective multicentric validation of biochemical markers (Fibrotest/Actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the Fibropaca study Hepatology 38 2003 68 [suppl.: Abstract]
17. A.M. Johnson, and J.T. Whicher Effect of certified reference material 470 (CRM 470) on national quality assurance programs for serum proteins in Europe Clin. Chem. Lab. Med. 39 2001 1123 1128
18. A.M. Johnson, T.B. Ledue, and M.F. Collins Commutability of the CRM 470 C-reactive protein value in the Dade Behring N high sensitivity CRP assay Clin. Chem. Lab. Med. 41 2003 177 182
19. J.J. Albers, S.M. Marcovina, and H. Kennedy International federation of clinical chemistry standardization project for measurements of apolipoproteins A-I and B: II. Evaluation and selection of candidate reference materials Clin. Chem. 38 1992 658 662
20. A. Vassault, M. Baud, M. Castanier, G. Dumont, J. Ingrand, and M. Mercier Recommendations for a comparison of techniques. F, Document, stage 3 Ann. Biol. Clin. (Paris) 50 1992 727 730
21. A. Vassault, D. Grafmeyer, J. de Graeve, R. Cohen, A. Beaudonnet, and J. Bienvenu Quality specifications and allowable standards for validation of methods used in clinical biochemistry Ann. Biol. Clin. (Paris) 57 1999 685 695
22. H. Passing, and W. Bablok Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II J. Clin. Chem. Clin. Biochem. 22 1984 431 445
23. J. Bienvenu, C. Doche, R. Later, J.C. Manceaux, F. Pontet, and M. Pressac Improvements from the reference material CRM 470 in the standardization of the determination of serum proteins Ann. Biol. Clin. (Paris) 55 1997 37 40
24. F. Dati, G. Schumann, L. Thomas, F. Aguzzi, S. Baudner, and J. Bienvenu Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists Eur. J. Clin. Chem. Clin. Biochem. 34 1996 517 520
25. T.B. Ledue, and A.M. Johnson Commutability of serum protein values: persisting bias among manufacturers using values assigned from the certified reference material 470 (CRM 470) in the United States Clin. Chem. Lab. Med. 39 2001 1129 1133